Stay updated with breaking news from Primary Biliary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced...
Drinking 3 to 4 cups of coffee a day reduces risk of liver cancer, study suggests By Catherine Park A recent study shows there may be a positive link between coffee consumption and bone health. A new study suggests people who drink between three to four cups of coffee a day are less likely to develop cancer or other severe illnesses as a result of chronic liver disease (CLD) as opposed to those who do not drink it. The study, published on June 22 in BMC Public Health, a peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of publi...
Read more about Cadila Healthcare rises after USFDA grants orphan drug designation for Saroglitazar Mg on Business Standard. Cadila Healthcare rose 0.69% to Rs 465.40 after the company was granted orphan drug designation by the US drug regulator for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC).